X4 PHARMACEUTICALS, INC (XFOR) Total liabilities 2018–2025
X4 PHARMACEUTICALS, INC (XFOR) total liabilities at each fiscal year-end, per SEC filings.
$104.2MFY2025 · since FY2018: $21.6M → $104.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.2M | -16.2% |
| FY2024 | $124.3M | +29.3% |
| FY2023 | $96.2M | +17.9% |
| FY2022 | $81.5M | +54.5% |
| FY2021 | $52.8M | +5.4% |
| FY2020 | $50.1M | +59.1% |
| FY2019 | $31.5M | +45.6% |
| FY2018 | $21.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross profitXFOR Gross marginXFOR Operating incomeXFOR Operating marginXFOR Operating cash flowXFOR Free cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Shareholders’ equityXFOR overview →